AI revolutionizes ophthalmology with oculomics for cardiovascular risk assessment

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology.

Latest data shows millions of eligible Americans have been disenrolled from Medicaid

More than 10 million people were disenrolled from Medicaid over the past six months, according to the latest data published by a KFF tracker. The

November 3, 2023

Are Trump Voters Predisposed to COVID Vax Side Effects?!

Republicans may be more likely to perceive and report side effects after COVID shots, including serious adverse events (AEs), findings from a cross-sectional study suggested.

March 30, 2024

Genprex’s Reqorsa gene therapy picks up orphan drug designation from FDA for SCLC – Pharmaceutical Technology

The market for SCLC treatments is forecasted to reach $2.3bn by 2029. Credit: Shutterstock/Anucha Tiemsom. In another win for Genprex’s Reqorsa immunogene therapy, The US

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.